Core Viewpoint - The stock of Peijia Bio-Medical (02565) has seen an increase of over 6%, currently trading at 65.95 HKD with a transaction volume of 5.08 million HKD, following the announcement of an extension of the lock-up period for cornerstone investors until April 30, 2026 [1] Group 1: Lock-up Period Extension - The original lock-up period's last day has been extended to December 31, 2025, after an initial extension [1] - Cornerstone investors collectively hold 9.5845 million H-shares, representing approximately 3.43% of the company's total issued H-shares [1] - Cornerstone investors have agreed not to reduce their holdings of related H-shares from the end of the original lock-up period until April 30, 2026 [1] Group 2: Investor Confidence - The company interprets the second extension of the lock-up period as a sign of confidence from cornerstone investors in the company's technological development and significant progress in major clinical milestones [1] - Cornerstone investors will continue to review the company's performance and may consider further extending the lock-up period based on real-time developments and achieved milestones [1]